Header Logo

Connection

Megan Lerner to Pancreas

This is a "connection" page, showing publications Megan Lerner has written about Pancreas.
Connection Strength

0.224
  1. Carriers of a novel frame-shift insertion in WNT16a possess elevated pancreatic expression of TCF7L2. BMC Genet. 2013 Apr 23; 14:28.
    View in: PubMed
    Score: 0.102
  2. [1,2-13C2]-D-glucose profiles of the serum, liver, pancreas, and DMBA-induced pancreatic tumors of rats. Pancreas. 2005 Nov; 31(4):337-43.
    View in: PubMed
    Score: 0.061
  3. Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling. Cancer Lett. 2015 Apr 10; 359(2):314-24.
    View in: PubMed
    Score: 0.029
  4. Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer. 2007 Mar 01; 120(5):1046-54.
    View in: PubMed
    Score: 0.017
  5. Mesothelin is overexpressed in pancreaticobiliary adenocarcinomas but not in normal pancreas and chronic pancreatitis. Am J Clin Pathol. 2005 Dec; 124(6):838-45.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.